ES519809A0 - Procedimiento para la obtencion de oxazolidin-2-onas. - Google Patents

Procedimiento para la obtencion de oxazolidin-2-onas.

Info

Publication number
ES519809A0
ES519809A0 ES519809A ES519809A ES519809A0 ES 519809 A0 ES519809 A0 ES 519809A0 ES 519809 A ES519809 A ES 519809A ES 519809 A ES519809 A ES 519809A ES 519809 A0 ES519809 A0 ES 519809A0
Authority
ES
Spain
Prior art keywords
onas
oxazolidin
procedure
obtaining
obtaining oxazolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES519809A
Other languages
English (en)
Other versions
ES8404338A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES8404338A1 publication Critical patent/ES8404338A1/es
Publication of ES519809A0 publication Critical patent/ES519809A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES519809A 1982-02-16 1983-02-15 Procedimiento para la obtencion de oxazolidin-2-onas. Granted ES519809A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823205457 DE3205457A1 (de) 1982-02-16 1982-02-16 Oxazolidin-2-one

Publications (2)

Publication Number Publication Date
ES8404338A1 ES8404338A1 (es) 1984-04-16
ES519809A0 true ES519809A0 (es) 1984-04-16

Family

ID=6155839

Family Applications (1)

Application Number Title Priority Date Filing Date
ES519809A Granted ES519809A0 (es) 1982-02-16 1983-02-15 Procedimiento para la obtencion de oxazolidin-2-onas.

Country Status (10)

Country Link
EP (1) EP0086403A3 (es)
JP (1) JPS58152872A (es)
AU (1) AU553328B2 (es)
CA (1) CA1198116A (es)
DE (1) DE3205457A1 (es)
ES (1) ES519809A0 (es)
HU (1) HU188531B (es)
IL (1) IL67907A (es)
PT (1) PT76229A (es)
ZA (1) ZA83993B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1323370C (en) * 1986-09-12 1993-10-19 Davis H. Crater Fluorochemical oxazolidinones
ATE194981T1 (de) * 1992-04-30 2000-08-15 Taiho Pharmaceutical Co Ltd Oxazolidinderivat und sein pharmazeutisch verträgliches salz
DK0710657T3 (da) 1994-11-02 1999-05-25 Merck Patent Gmbh Adhæsionsreceptor-antagonister
WO2010061366A1 (en) * 2008-11-28 2010-06-03 Corden Pharma Ip Limited Manufacture of bisoprolol and intermediates therefor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB834968A (en) * 1957-08-28 1960-05-18 Robins Co Inc A H 5-o-alkoxyphenoxymethyl-2-oxazolidones
FR1284520A (fr) * 1958-11-03 1962-02-16 American Cyanamid Co Procédé de préparation de nouveaux composés de 2-oxazolidinones
US3299088A (en) * 1959-06-19 1967-01-17 Robins Co Inc A H Halo-substituted phenoxymethyl oxazolidones
US3062828A (en) * 1962-02-27 1962-11-06 Robins Co Inc A H 5-(alkoxyphenoxymethyl)-2-oxazolidones
CH490405A (de) * 1965-07-09 1970-05-15 Ciba Geigy Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH484173A (de) * 1965-07-09 1970-01-15 Ciba Geigy Verfahren zur Herstellung eines neuen Oxazolidinons
CH462815A (de) * 1965-11-17 1968-09-30 Ciba Geigy Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
FR2038200A1 (es) * 1969-04-03 1971-01-08 Ciba Geigy Ag
FR2338268A1 (fr) * 1976-01-16 1977-08-12 Nativelle Spa Nouveaux derives d'oxazolidinone, preparation et application a la synthese d'aryloxypropanolamines

Also Published As

Publication number Publication date
AU1087683A (en) 1983-08-25
CA1198116A (en) 1985-12-17
AU553328B2 (en) 1986-07-10
ES8404338A1 (es) 1984-04-16
HU188531B (en) 1986-04-28
IL67907A0 (en) 1983-06-15
EP0086403A3 (de) 1984-10-10
PT76229A (en) 1983-03-01
EP0086403A2 (de) 1983-08-24
JPS58152872A (ja) 1983-09-10
ZA83993B (en) 1983-11-30
IL67907A (en) 1986-10-31
DE3205457A1 (de) 1983-08-25

Similar Documents

Publication Publication Date Title
ES519810A0 (es) Procedimiento para la obtencion de liposomas unilaminares.
ES515084A0 (es) Procedimiento para la obtencion de 2-arilimidazopiridinas.
ES523064A0 (es) Procedimiento para preparar azetidinas.
ES520273A0 (es) Procedimiento para la obtencion de trimetilolpropano.
ES524346A0 (es) Procedimiento para la obtencion de poliaminas primarias.
ES522689A0 (es) Procedimiento para la obtencion de bentonita.
ES515445A0 (es) Procedimiento para la obtencion de amino-organoaminosilosanos.
ES526042A0 (es) Procedimiento para la obtencion de azolilbutanoles
ES507523A0 (es) Procedimiento para la obtencion de disulfuros de xantogeno.
ES516842A0 (es) Procedimiento para la obtencion de benzofuranonas.
ES520119A0 (es) Procedimiento para la obtencion de n-vinilacilaminas ciclicas.
ES520579A0 (es) Procedimiento para la preparacion de eteres oximicos.
ES532240A0 (es) Procedimiento para la obtencion de benzoil-ureas.
ES501347A0 (es) Procedimiento para la obtencion de cianguanidina trisusti- tuidas, de efecto fungicida
ES521813A0 (es) Procedimiento para preparar alcohil-polisacaridos.
ES520531A0 (es) Procedimiento para preparar tioeteres.
ES518617A0 (es) Procedimiento para la obtencion de p-tercioctil-fenol.
ES525257A0 (es) Procedimiento para la obtencion de poliamido-imidas
ES522323A0 (es) Procedimiento para la obtencion de 2-halogenopropionatos sustituidos.
ES502951A0 (es) Procedimiento para la obtencion de 4-aralquil-1,4-dihidro- pirdinas
ES522474A0 (es) Procedimiento para la obtencion de halogenopropargilformamidas.
ES520706A0 (es) Procedimiento para la preparacion de sulfonilureas.
ES519809A0 (es) Procedimiento para la obtencion de oxazolidin-2-onas.
ES532635A0 (es) Procedimiento para la obtencion de tetrahidrotiopiran-3, 5-dion-4-carboxamidas
ES523287A0 (es) Procedimiento para la obtencion de hidantoinas n-sulfeniladas.